The oxazolidinone antibiotic linezolid targets the peptidyl transferase center (PTC) on the bacterial ribosome. A group of 13 single and 4 double 23S rRNA mutations has been introduced into a Mycobacterium smegmatis strain with a single rRNA operon.
Introduction
The bacterial ribosome is an important target for many clinically relevant antibiotics including linezolid that is effective in the treatment of infections with various multidrug-resistant Gram-positive cocci, especially methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci (26) . Several lines of evidence have established that oxazolidinones bind to the PTC on the large ribosomal subunit. The evidence includes competitive binding studies with chloramphenicol and lincomycin (25) , the clustering of single rRNA resistance mutations in the peptidyl transferase loop (22) , in vivo crosslinking experiments (4, 23) and crystal structures of linezolid-50S subunit complexes (archaeal 50S complex, (20) ; bacterial 50S complex, (49) ). These structures show that linezolid binds to the A-site portion of the PTC ( Figure 1A ) overlapping the site of the aminoacyl moiety of A-site bound tRNA (20, 49) . The linezolid binding pocket is lined by eight 23S rRNA nucleotides (marked by wedges in Figure 1B ) that are highly conserved among the three domains of life (49) and the drug is not in direct contact with any ribosomal proteins. Despite this high conservation, indirect evidence suggests that linezolid affects bacterial and mitochondrial ribosomes but not cytosolic ribosomes (23, 34) . It has been proposed that the specificity may be determined by nucleotides a bit further away from the binding site acting through the nearby conserved nucleotides (23) .
The linezolid resistance mechanisms characterized thus far involve alteration at or around the PTC by modification or mutation. Methylation of the 23S rRNA positions at the PTC (5, 13, 45, 46, 49) . In contrast, lower linezolid susceptibility was found in Streptococcus pneumoniae by abolished methylation of G2445 in 23S rRNA (9) . Hence both gain and loss of methylations in the PTC area can affect linezolid binding. In addition, it has been shown that pseudouridylation of 23S rRNA nucleotide U2504 leads to a 16-fold decrease in linezolid susceptibility (47) . experiments to confer reduced susceptibility to linezolid in S. pneumoniae (50) . In addition, a number of other mutations in 23S rRNA and ribosomal proteins L3 (28, 29) and L4 (9, 51) have been associated with linezolid resistance, but without substantial documentation of the cause-effect relationship. The 23S rRNA mutations reported sometimes correspond to those found in laboratory selection experiments but in others cases there is no genetic evidence relating the specific 23S rRNA mutations to the linezolid resistance phenotype (3, 9, 27, 41) . 
Materials and Methods

Strains and plasmids
The M. smegmatis strains and plasmids used in this investigation are summarized in Table 1 . The strains all possess a single rRNA operon encoded on a plasmid integrated at a chromosomal attB locus. The integrated plasmid carries a gentamicin resistance cassette in the parent strain (SZ558) and a hygromycin B resistance cassette in the wildtype and mutant strains (16) . As a note, our rrnA and rrnB designations are reversed relative to the ones in the annotated M. smegmatis mc 2 155 genome. The E. coli strain DH5α was grown in LB medium. M. smegmatis strains were grown in LB Tween (LB supplemented with 0.05% Tween 80) to minimize cell clumping. For plasmid selection and maintenance, LB agar plates were supplemented with streptomycin (50 µg mL -1 ), gentamicin (15 µg mL -1 ), or hygromycin B (100 µg mL -1 ).
fragment, where primers OPF3 (5'-GAGTGATCTACCCATGGCCAG-3') and OPR3
(5'-GTGCCCCTGGTGGGACAACTG-3') were used in combination with mutagenic primers (Table A1 ). The OPF3 and OPR3 primers were also used to amplify a 2.1 kb fragment containing the C2055A mutation from the SMR5 ∆rrnB rrnA 2055A strain (Table 1 ) (30) using colony PCR. These mutant fragments were subsequently cloned into the NcoI and SpeI sites of pMIH∆int-rrnB (16) . The other single mutations were introduced either onto 2.6 kb fragments using the OPF4 (5'-GACCAAGGGTTCCTGGGCCAG-3') and OPR4 (5'-CGAGTCGCGACGTACGTTCG -3')/OPR5 (5'-TCGAGCTCGGTACCTACGTAC-3') primers (A2453U, C2499A, C2499U, U2504G, A2572U, G2576U) or 2.0 kb fragments using the OPF5 (5'-GGTTTGTGTAGGATAGGTGGG-3') and OPR7 (5'-GGTCGAGAAGTAACAGGG-3') primers (A2503G, G2505A, C2571G, C2612A) used in combination with mutagenic primers (Table A1) , where both fragments contain the 3'-end of 23S rDNA, 5S rDNA, and pMIH∆int-rrnB plasmid sequence including the MunI site. These fragments were subsequently cloned into the SpeI and MunI sites of pMIH∆int-rrnB. Double mutations were introduced by ligation of either NcoI-SpeI or SpeI-MunI fragments containing one mutation into the corresponding cut pMIH∆int-rrnB plasmids containing the second mutation. The ligated plasmids were transformed into E. coli DH5α, followed by sequencing of plasmid DNA with primer SP1F (5'-CCTGCACGAATGGCGTAACG-3') or SP2F (5'-GAGACGGACATGTCGAGCAG-3') to verify the presence of the mutations.
Transformation of plasmids into competent M. smegmatis cells was performed essentially as described previously (43) except that cultures were grown in LB Tween medium and the cells were plated onto LB hygromycin B + 5% sucrose plates. The transformation plates were incubated at 37˚C for 3-5 days or until single colonies on July 7, 2017 by guest http://aac.asm.org/ were visible. Single colonies were reisolated on LB hygromycin B + 5% sucrose plates and screened for loss of the pMIG-sacB-rrnB plasmid by testing for gentamicin sensitivity by patching cells on LB gentamicin plates. Colony PCR with the primers OPF4 and OPR3 was used to amplify fragments containing the mutations, followed by sequencing of the fragments with primers SP1F and/or SP2F to ensure that the mutations had not reverted during the plasmid exchange process.
Growth rate measurements
Cells from freshly streaked agar plates were used to inoculate 5 mL LB Tween media and the cultures were incubated at 37˚C for 1-3 days. The cultures were diluted into 5 mL LB Tween and grown at 37˚C prior to dilution into 25 or 50 mL LB Tween.
The growth rates in the exponential growth phase were determined by growing strains in 25 or 50 mL LB Tween at 37˚C with constant shaking. The OD 600 values were recorded every hour for 7-12 hours. The data were fit to the exponential function, OD = OD 0 e µt , where µ is the growth rate and OD 0 is the optical density at time zero. The doubling times, t d , were calculated from the growth rates, where t d = (ln2/µ), and represent the average of 3-7 independent experiments. In some strains, cell clumping and/or very slow growth prevented determination of exact growth rates.
Drug susceptibility testing
The drug susceptibility assay was carried out in 96-well microtiter plate format, where plates were read manually. Cells from freshly streaked agar plates were used to inoculate 5 mL LB Tween media and the cultures were incubated at 37˚C until growth was clearly visible. The cultures were diluted to OD 600 = 0.02 and 100 µL was mixed with 100 µL of antibiotic solutions in a series of twofold dilution steps. The 
Results
The model system and procedure for rRNA mutant isolation smegmatis SMR5 ∆rrnA ∆rrnB attB::pMIG-sacB-rrnB. Plasmid exchange at the attB locus was achieved by selection with hygromycin B and sucrose (16) . As expression of the sacB gene encoding the enzyme levansucrase from Bacillus subtilis is lethal in M. smegmatis in the presence of sucrose, it can be used as a marker for positive selection of gene replacement events (35, 36) . In a previously used M. smegmatis model system, the mutations were introduced by homologous recombination followed by selection with the antibiotic the mutation was thought to confer resistance to (30) .
Thus, the strength of the model system implemented here is the ability to introduce mutations that don't necessarily confer antibiotic resistance.
Single 23S rRNA mutations associated with domain specificity in the PTC area
Most antibiotics are specific for ribosomes from one or two domains of life, although a few universal antibiotics inhibit ribosomes from all three domains. Indeed, The G2032C, A2453U and C2499U single mutations have been introduced into M.
smegmatis 23S rRNA to convert their identity to that found in human cytosolic 28S
rRNA to investigate their effect on linezolid susceptibility. The positions of the nucleotides relative to linezolid is illustrated in Figure 1C . The A2058G mutation that confers macrolide resistance (38, 48) was included as a control mutation not expected on July 7, 2017 by guest http://aac.asm.org/ to affect linezolid susceptibility. The linezolid susceptibility of the mutant strains was assayed by measurement of minimal inhibitory concentrations (MIC) and are shown in Table 2 . There are only two-fold increases in linezolid MICs for the G2032C and A2453U mutants (Rows 4-5. Table 2 ), whereas MICs for the C2499U and A2058G mutants (Rows 6 and 3, Table 2 ) are the same as the wildtype strain. It is thus clear that these mutations do not lead to significantly reduced linezolid susceptibility.
Cross resistance was investigated by determining MICs for chloramphenicol, clindamycin, and valnemulin for the mutant strains ( Table 2 ). These antibiotics have partially overlapping binding sites with linezolid as known from crystal structures of 50S subunit-antibiotic complexes (20, 45, 46, 49) . Although the streptogramin A binding site overlaps that of linezolid (13, 30, 49) , the parent and wildtype strains
were not sensitive to the streptogramin A antibiotic virginiamycin M 1 (data not shown). The MIC values for virginiamycin and Synercid, each containing streptogramin A and B components, were also determined. However, the streptogramin MICs of the mutant strains differed from the wildtype strain by no more than two-fold (data not shown). The G2032C mutation confers considerable resistance to valnemulin and clindamycin (Row 4, Table 2 ). As expected, the control A2058G mutation is highly resistant to clindamycin (39) (Row 3, Table 2 ). There are only two-fold increases in valnemulin MICs for the A2058G and A2453U mutants and none of the four mutants (Rows 3-6, Table 2 ) exhibit chloramphenicol resistance. The MIC values show that all mutations confer reduced susceptibility to linezolid, albeit to different extents. The largest effect is observed with the G2576U mutant, with a 32-fold increase in linezolid MIC compared to the wildtype strain (Row 10, Table 2 ). Moderate four-and eight-fold increases in linezolid MICs are observed with the first layer A2503G and G2505A mutants, respectively (Rows 7-8, Table 2 ). Only two-fold increases in linezolid MIC are observed with the outer layer C2571G and C2612A mutants (Rows 9 and 11, Table 2 ). According to the common secondary structure ( Figure 1B Table 2 ), and a two-fold increase and decrease for the A2572U and C2055A mutants, respectively (Rows 20 and 18, Table 2 ). Changes in chloramphenicol MICs are observed for the U2504G (8-fold increase) and A2572U (4-fold decrease) mutants. Table 2 ). There are thus synergistic effects on linezolid resistance, as the double mutations confer higher linezolid MICs than the additive effects of the two single mutations. The G2032A-U2504G mutant exhibits an eight-fold increase in linezolid MIC with respect to the U2504G mutant, indicating that the G2032A single mutation that does not confer linezolid resistance can contribute significantly to resistance in combination with the U2504G mutation (Rows 14-16, Table 2 ). The four-fold linezolid MIC increase in the G2032A-C2499A mutant shows that although the two single mutations do not confer linezolid resistance alone, they confer resistance when present together (Rows 12-14, Table 2 ). Moreover, the C2055A-U2504 mutant exhibits a four-fold increase in linezolid MIC relative to the U2504G mutant and the C2055A-A2572U mutant exhibits a 16-fold increase relative to the A2572U mutant. These data demonstrate on July 7, 2017 by guest http://aac.asm.org/ that even though the C2055A single mutation confers hypersensitivity to linezolid, it can contribute significantly to linezolid resistance when in combination with either the U2504G or A2572U mutations (Rows 17-19, Table 2 ). There is also a synergistic effect on clindamycin resistance with the C2055A-A2572U mutant, where there is a 16 to 32-fold MIC increase relative to the wildtype and the C2055A and A2572 mutant strains (Rows 19, 18, and 20, Table 2 ). There are small increases and decreases in chloramphenicol and valnemulin MICs for the double mutant relative to their corresponding single mutant strains, but no synergistic effects are observed for these antibiotics.
Effect of the 23S rRNA mutations on growth rate
A mutation preventing antibiotic binding is only beneficial if it is not causing too much harm otherwise. The single and double 23S rRNA mutations summarized in Table 2 were successfully introduced into M. smegmatis, and are thus not lethal in this organism. Generation times of the mutant strains were measured to determine the effect of the introduced mutations and are shown in Table 2 . The wildtype control strain with the pMIH-rrnB plasmid and a generation time of 3.5 hr has a slightly slower growth rate than the parent strain with the pMIG-sacB-rrnB plasmid and a generation time of 3.3 hr. The single G2032A, A2058G and A2572U 23S rRNA mutations do not cause significant changes in growth relative to the wildtype strain.
The C2055A, A2453U and C2499A mutations lead to small decreases in growth rate hr, respectively. Although precise growth rates could not be obtained for the G2032A-U2504G and C2055A-U2504G mutants due to cell clumping, we estimate that these strains have doubling times that are longer than 10 hours.
Discussion
The 23S rRNA nucleotides G2061, A2451, C2452, A2503, U2504, G2505, U2506
and U2585 interact directly with bound linezolid and are all universally conserved and packed in a RNA-only cluster at the PTC (20, 49) (Fig. 1C) . As there are quantitative differences in linezolid binding to ribosomes from the three domains of life, specificity is likely influenced by nucleotides at a distance that cause subtle conformational changes as also discussed elsewhere (6, 12, 40) . This also applies to other antibiotics that bind to the PTC such as chloramphenicol, clindamycin and valnemulin. In an attempt to locally mimic the eukaryotic ribosomal structure around the linezolid binding site, the three 23S rRNA changes G2032C, A2453U and C2499U were introduced at positions located on the opposite side of U2504 relative to linezolid (Fig. 1C) (6, 12, 40) . Only very moderate decreases in linezolid susceptibility were observed for G2032C and A2453U (Rows 4 and 5, Table 2 ) even though elevated MICs have been reported for G2032C,U mutations in E. coli (52) .
There was no MIC increase for C2499U (Row 5, Table 2 ), in contrast to a study in Starting directly at the linezolid binding pocket (blue nucleotides, Figure 1C ), the A2503G, U2504G and G2505A mutations confer significant although only up to an eight-fold increase in linezolid resistance (Rows 7, 16, 8, Table 2 ). U2504 interacts directly with linezolid ( Figure 1E ) and U2504G confers reduced susceptibility to linezolid. In our previous work on tiamulin resistance, mutations were found nearby and at U2504 and we suggested that the mutations affected antibiotic binding indirectly through an effect on U2504 (40). The contributions from the individual mutations were not proven at that time but have been verified in our recent paper (30) and herein. All the mutations introduced at second-layer nucleotides (green nucleotides, Figure 1C ) exhibit linezolid susceptibility changes not higher than fourfold except G2576U that shows a 32-fold increase in linezolid MIC (Row 10, Table   2 ). The G2576U data is not surprising as this mutation has been observed in clinical isolates and laboratory strains of staphylococci, enterococci, and S. pneumoniae (3, 8, on July 7, 2017 by guest http://aac.asm.org/ Downloaded from 9, 32, 33, 41) . However, the G2576U mutation results in three-fold slower growth of M. smegmatis. This is consistent with a previous study, where only the G2447U mutation was isolated by selection in the presence of linezolid (43). The G2576U mutation is either not so detrimental in other bacteria or perhaps compensatory mutations, which we are unaware of, are rapidly acquired for a better cost-benefit ratio. According to the D. radiodurans 50S-linezolid structure (49) the closest distance from linezolid to G2576 is 7.9 Å (Figure 1C ), but a G2576U mutation will presumably reduce the degree of stacking with G2505 and disrupt a hydrogen bond with the U2506 backbone that abuts the bound linezolid ( Figure 1D ) and thereby decrease linezolid binding. This is in accordance with data from Haloarcula marismortui with the PTC antibiotic anisomycin suggesting that mutations outside the antibiotic binding site can confer resistance by inducing increased disorder in the drug binding pocket (2) . Moreover, a recent study of the structural basis of cross resistance for PTC antibiotics advocates the idea of remote mutations affecting the antibiotic binding sites (6). There are no or minor changes observed in linezolid MICs for single mutations in the third or outer layer (orange and red nucleotides, Figure 1C ) but it cannot be ruled out that they can have a larger effect in other bacteria. In summary, the RNA mutations conferring linezolid resistance in other organisms also do so in M.
smegmatis, although the resistance levels are small except for G2576U. The A2503G, G2505A, C2571G, and C2612A mutations reported in the literature without genetic proof confer some resistance in M. smegmatis.
There have been few attempts to evaluate the effect of double rRNA mutations. Antibiotic resistance occurring stepwise could very likely proceed through accumulation of several mutations working additively or even synergistically. In our previous study with tiamulin, the double mutations G2032A-U2504G, G2032A- All of the nucleotides changed in the double mutations are clustered on the opposite side of U2504 relative to the bound linezolid drug ( Figure 1E ) and while two of the double mutations involve nucleotides that are located next to each other (C2055A-A2572U, U2504G-C2055A), the other two involve nucleotide pairs that are too distant to interact directly (G2032A-C2499A, G2032A-U2504G). The closest distance between G2032 and C2499 is 5.8Å and this double mutation presumably disturbs interactions to A2572 and C2055 that are close to G2032 and C2499, respectively ( Figure 1E ), which in turn affects U2504. As the A2572 nucleotide is sandwiched between G2032 and U2504, the G2032A-U2504G double mutation probably involves direct perturbations of A2572 and G2504 in the binding cavity. We by stabilizing a conformation that is nonproductive for linezolid binding.
One issue is how much resistance a mutation can provide and another is how well the mutation is tolerated. As the PTC contains many conserved nucleotides it is to be expected that mutations might cause slower growth. Surprisingly few of the mutants studied here severely inhibit growth except the double mutants. Three of the four double mutants (Rows 15, 17, and 19, Table 2 ) grow very slowly, which implies that this functionally important region accepts subtle single changes but not too many changes together. It is questionable that such deleterious double mutations will ever appear in a natural setting.
Although cross resistance between PTC antibiotics from 23S rRNA mutations is common there is not a simple relationship between overlapping binding sites and cross resistance. Our data clearly illustrate the complexity of cross resistance related to rRNA mutations. For example, the third layer G2032C mutation confers resistance to valnemulin and clindamycin but not to linezolid and chloramphenicol.
Furthermore, the G2032A mutation yields the same valnemulin resistance as G2032C the mutational effects at this position on linezolid susceptibility are species-specific (52). The A2503G and the G2505A mutations confer some resistance to linezolid and cross resistance to chloramphenicol but no resistance to clindamycin and valnemulin.
The G2576U mutation is the only single mutation providing high resistance to both linezolid and chloramphenicol, as well as a 2 to 4-fold increase in clindamycin resistance. The U2504G mutation provides a four-fold reduced sensitivity for linezolid and high resistance to chloramphenicol, but when combined with C2055A
(not providing significant resistance) the synergistic effect yields a much higher In summary, mutation of individual nonconserved nucleotides outside the linezolid binding site does not account for the species specificity of PTC antibiotics.
The study illustrates that mutations at some distance from an antibiotic binding site can confer resistance and the same rRNA mutation can have significantly different 
